CTIS.eu › Cities › Latvia › Liepaja
Liepaja
Latvia
43 total trials
17 recruiting
2022-500953-17-00
4
2023-03-23
Moderately to severely active ulcerative colitis
2023-507795-51-00
5
2022-05-17
atherosclerotic heart and blood vessel disease (the narrowing of arter
2023-506680-34-00
5
2022-03-24
Non-Muscle Invasive Bladder Cancer
2024-510735-21-00
5
2021-11-26
Atherosclerotic cardiovascular disease (ASCVD)
2023-503831-17-00
4
2019-12-23
The treatment of participants with HRRm and/or HRD-positive cancer
2023-505478-14-00
5
2019-05-09
Psoriatic Arthritis
2022-501017-31-00
5
2016-05-10
Rheumatoid arthritis
2022-502049-91-00
4
2023-09-26
SEVERE COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (SCABP)
2023-507705-34-00
5
2025-08-29
Moderate to Severe Active Ulcerative Colitis
2023-506664-14-00
5
2024-10-24
Rheumatoid Arthritis
2023-508602-14-00
4
2024-06-27
Thromboembolic disease
2023-503785-22-00
5
2024-03-25
complicated urinary tract infection (cUTI) or acute pyelonephritis (AP
2022-501470-18-00
4
2023-06-26
Thromboembolic disease
2024-515180-56-00
5
2023-06-26
Complicated urinary tract infection (cUTI), acute uncomplicated pyelon
2024-516385-10-00
4
2023-05-02
Acute Bacterial Skin and Skin Structure Infections
2023-510195-31-00
4
2023-01-03
Idiopathic or Diabetic Gastroparesis
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
2024-513992-42-00
10
2022-09-13
venous thromboembolism (VTE) in patients with gastrointestinal/genitou
2023-509569-19-00
10
2022-08-10
venous thromboembolism (VTE)
Showing 25–43 of 43 trials